Published in Pediatr Infect Dis J on November 01, 2007
The NICHD International Site Development Initiative perinatal cohorts (2002-09). Int J Epidemiol (2011) 1.25
Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants. AIDS (2008) 1.09
TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns. PLoS One (2013) 0.87
Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025. J Pediatric Infect Dis Soc (2012) 0.85
Safety and tolerability of antiretrovirals during pregnancy. Infect Dis Obstet Gynecol (2011) 0.82
Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding. J Acquir Immune Defic Syndr (2015) 0.78
Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir. Infect Dis Obstet Gynecol (2016) 0.75
Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis (2004) 5.93
Pregnancy and infection. N Engl J Med (2014) 4.15
Reduced lopinavir exposure during pregnancy. AIDS (2006) 3.98
Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr (2008) 2.38
Diagnosis of HIV-1 infection in children younger than 18 months in the United States. Pediatrics (2007) 2.08
Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J (2008) 2.00
Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth. AIDS (2006) 1.99
A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS (2006) 1.96
Early immunological predictors of neurodevelopmental outcomes in HIV-infected children. Clin Infect Dis (2009) 1.68
Lopinavir exposure with an increased dose during pregnancy. J Acquir Immune Defic Syndr (2008) 1.65
Breast-feeding and Transmission of HIV-1. J Acquir Immune Defic Syndr (2004) 1.56
Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. J Acquir Immune Defic Syndr (2011) 1.55
Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024. AIDS (2005) 1.49
Predictors of repeat pregnancy among HIV-1-infected women. J Acquir Immune Defic Syndr (2007) 1.48
Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. American Academy of Pediatrics Committee on Pediatric AIDS. Pediatrics (2003) 1.41
The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol (2006) 1.37
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr (2010) 1.35
Lopinavir tablet pharmacokinetics with an increased dose during pregnancy. J Acquir Immune Defic Syndr (2010) 1.33
Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database Syst Rev (2009) 1.29
In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. AIDS Patient Care STDS (2011) 1.26
Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis. AIDS Behav (2010) 1.26
Atazanavir pharmacokinetics with and without tenofovir during pregnancy. J Acquir Immune Defic Syndr (2011) 1.24
Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDS (2012) 1.20
A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers. Am J Epidemiol (2012) 1.17
HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers. AIDS (2006) 1.15
Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia. Sex Transm Dis (2006) 1.13
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis (2003) 1.11
Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. J Acquir Immune Defic Syndr (2010) 1.10
Predictors of stillbirth in sub-saharan Africa. Obstet Gynecol (2007) 1.10
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J (2012) 1.06
Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. J Acquir Immune Defic Syndr (2010) 1.05
Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis. AIDS (2007) 1.04
Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study. Pediatr Infect Dis J (2005) 1.04
Mode of delivery and postpartum morbidity in Latin American and Caribbean countries among women who are infected with human immunodeficiency virus-1: the NICHD International Site Development Initiative (NISDI) Perinatal Study. Am J Obstet Gynecol (2006) 1.04
Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women. Am J Clin Nutr (2008) 1.04
Participation of HIV-infected pregnant women in research in the United States. AIDS Res Hum Retroviruses (2007) 1.02
Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms. J Acquir Immune Defic Syndr (2004) 1.01
HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population. Am J Obstet Gynecol (2006) 1.00
Pregnancy and infection. N Engl J Med (2014) 0.99
Tolerance and safety of different concentrations of chlorhexidine for peripartum vaginal and infant washes: HIVNET 025. J Acquir Immune Defic Syndr (2004) 0.98
Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. J Infect Dis (2005) 0.98
Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: plasma versus PBMCs. AIDS Res Hum Retroviruses (2008) 0.98
Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1, 2015-July 7, 2016. MMWR Morb Mortal Wkly Rep (2016) 0.98
Maternal neutralizing antibody and transmission of hepatitis C virus to infants. J Infect Dis (2008) 0.97
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents. Pediatr Infect Dis J (2010) 0.97
Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants. Int J Infect Dis (2010) 0.97
Impact of pregnancy on abacavir pharmacokinetics. AIDS (2006) 0.95
Relationship between mortality and feeding modality among children born to HIV-infected mothers in a research setting: the Kesho Bora study. AIDS (2013) 0.95
Analysis of HIV type 1 diversity in pregnant women from four Latin American and Caribbean countries. AIDS Res Hum Retroviruses (2006) 0.94
Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NISDI perinatal study. Pediatr Infect Dis J (2007) 0.92
Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa. Pediatrics (2009) 0.92
Postpartum changes in plasma viral load and CD4 percentage among HIV-infected women from Latin American and Caribbean countries: the NISDI Perinatal Study. Mem Inst Oswaldo Cruz (2011) 0.92
Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study. J Infect Dis (2004) 0.91
Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City. Int J Infect Dis (2013) 0.91
Incidence of Zika Virus Disease by Age and Sex - Puerto Rico, November 1, 2015-October 20, 2016. MMWR Morb Mortal Wkly Rep (2016) 0.90
Knowledge and practice of prechewing/prewarming food by HIV-infected women. Pediatrics (2011) 0.89
Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol. BMC Pediatr (2009) 0.88
CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption. J Acquir Immune Defic Syndr (2011) 0.88
Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy. J Infect Dis (2008) 0.88
CD4/CD8 T-cell ratio predicts HIV infection in infants: the National Heart, Lung, and Blood Institute P2C2 Study. J Allergy Clin Immunol (2007) 0.88
Postpartum weight change among HIV-infected mothers by antiretroviral prophylaxis and infant feeding modality in a research setting. AIDS (2014) 0.88
CD4+/CD8+ T cell ratio for diagnosis of HIV-1 infection in infants: Women and Infants Transmission Study. Pediatrics (2008) 0.87
Placental malaria and mother-to-child transmission of human immunodeficiency virus-1. Am J Trop Med Hyg (2009) 0.87
Research on vaccines during pregnancy: protocol design and assessment of safety. Vaccine (2013) 0.87
Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study. Pediatr Infect Dis J (2015) 0.87
Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments. Vaccine (2013) 0.86
Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment. J Acquir Immune Defic Syndr (2009) 0.85
HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Cytometry B Clin Cytom (2007) 0.85
Changes in sexual behaviour among HIV-infected women in west and east Africa in the first 24 months after delivery. AIDS (2012) 0.84
Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa. Pediatr Infect Dis J (2008) 0.84
Validity and reliability of a self-efficacy expectancy scale for adherence to antiretroviral therapy for parents and carers of children and adolescents with HIV/AIDS. J Pediatr (Rio J) (2008) 0.84
Population attributable fractions for late postnatal mother-to-child transmission of HIV-1 in Sub-Saharan Africa. J Acquir Immune Defic Syndr (2010) 0.84
The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis. Pediatrics (2005) 0.83
Prevention of mother-to-child transmission of HIV-1: the role of cesarean delivery. Clin Perinatol (2010) 0.83
Antiretroviral interventions for preventing breast milk transmission of HIV. Cochrane Database Syst Rev (2014) 0.83
Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia. Int J Gynaecol Obstet (2009) 0.83
Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications. Pediatr Infect Dis J (2011) 0.83
Insulin resistance and glucose and lipid concentrations in a cohort of perinatally HIV-infected Latin American children. Pediatr Infect Dis J (2013) 0.82
Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. S Afr Med J (2010) 0.81
Short communication: immunogenicity of an inactivated influenza vaccine and postvaccination influenza surveillance in HIV-infected and noninfected children and adolescents. AIDS Res Hum Retroviruses (2011) 0.81
Infant feeding modes and determinants among HIV-1-infected African Women in the Kesho Bora Study. J Acquir Immune Defic Syndr (2013) 0.81
Early infant feeding patterns and HIV-free survival: findings from the Kesho-Bora trial (Burkina Faso, Kenya, South Africa). Pediatr Infect Dis J (2015) 0.81
Progress in overcoming barriers to influenza immunization of pregnant women. Am J Obstet Gynecol (2012) 0.81
Laboratory abnormalities among HIV-1-infected pregnant women receiving antiretrovirals in Latin America and the Caribbean. AIDS Patient Care STDS (2008) 0.81
Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants. J Acquir Immune Defic Syndr (2010) 0.80
T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines. AIDS Res Hum Retroviruses (2010) 0.80
Antiretroviral use during pregnancy for treatment or prophylaxis. Expert Opin Pharmacother (2011) 0.80
Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study. AIDS (2006) 0.79
Association of Body Mass Index of HIV-1-Infected Pregnant Women and Infant Weight, Body Mass Index, Length, and Head Circumference: The NISDI Perinatal Study. Nutr Res (2007) 0.79
Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes. Pediatr Infect Dis J (2016) 0.79
Trends in the management and outcome of HIV-1-infected women and their infants in the NISDI Perinatal and LILAC cohorts, 2002-2009. Int J Gynaecol Obstet (2013) 0.79
Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected women. Obstet Gynecol (2010) 0.79
Body composition in prepubertal, HIV-infected children: a comparison of bioelectrical impedance analysis and dual-energy X-ray absorptiometry. Nutr Clin Pract (2013) 0.78
Evaluation of hematological, virologic and anthropometric parameters as progression markers in HIV-1 infected children. J Pediatr (Rio J) (2009) 0.78